Creating collaborations

Expansion of EIE collaborations with DKFZ and corresponding centers in Italy (CNAO – Hadron Academy), France, the UK, and the US

Expansion of the Center of Excellence’s collaborations for the development of advanced organic materials and innovative approaches to cancer diagnosis and treatment (theranostics) of cancer and bioelectronic applications with leading research institutions, such as the German Cancer Research Center (DKFZ) and corresponding centers in Italy (CNAO – Hadron Academy), France, the United Kingdom, and the United States, is a strategic move of great importance for the National Research Foundation (NRF).

These collaborations strengthen the Foundation’s international presence, provide it with access to advanced technologies and know-how, and expand its research and clinical capabilities. Through these international partnerships, the Center of Excellence incorporates the latest developments in molecular imaging, targeted therapy, and personalized medical interventions against cancer.

The collaborating institutions have specialized technologies, such as proton therapy and the use of heavy ions (hadrons) in radiotherapy, with which the NHRF has direct contact, thus broadening its field of research and upgrading its clinical applications. The collaboration with DKFZ, one of the largest cancer research centers in the world, provides access to cutting-edge programs, clinical trials, and large-scale biomarker analysis platforms.

At the same time, the connection with CNAO – Hadron Academy in Italy strengthens technology transfer in the innovative use of heavy ions, while collaboration with research centers in France, the United Kingdom, and the United States ensures interconnection with pioneers in cancer treatment and diagnosis.

These strategic synergies increase the attractiveness of the Center of Excellence for young researchers and scientists, strengthening the human resources of the NHRF. At the same time, they promote the securing of additional international funding through joint research programs and facilitate the participation of the NHRF in large European and international research networks.

In addition, the exchange of know-how and the implementation of joint protocols strengthen translational research and accelerate the clinical application of innovative diagnostic and therapeutic methods, directly contributing to the improvement of cancer patient care.

In this way, the NHRF is establishing itself as a leading research institution in the fight against cancer, with a strong international footprint and ongoing contribution to biomedical research.

Strategic Collaborations through Memoranda and Protocols of Cooperation

Another key area for the National Hellenic Research Foundation (NHRF) concerns the memoranda and cooperation protocols signed with public bodies and charitable foundations in Greece and abroad. A total of 16 new memoranda of cooperation and 3 new protocols were signed during the period 2023–2025, significantly strengthening the NHRF’s ties with universities, research centers, and businesses, both nationally and internationally.

Indicative examples include collaborations with the Agricultural University of Athens, the University of Patras, the University of West Attica, as well as with institutions such as NIMTS, the Bodossaki Foundation, and the General Anticancer Hospital “Agios Savvas”.

These collaborations, which cover the entire range of NHRF activities, highlight its institutional role as a catalyst in connecting the academic/research community with the business and clinical sectors, as well as with society at large.